Ajuwon Kolapo M, Spurlock Michel E
Department of Animal Sciences, Center for Comparative Medicine, Purdue University, West Lafayette, IN 47907-2054, USA.
J Nutr. 2005 Aug;135(8):1841-6. doi: 10.1093/jn/135.8.1841.
Fatty acids and their metabolites regulate gene expression and immunological pathways. Furthermore, obese individuals frequently have increased circulating fatty acid concentrations, and localized inflammation in adipose tissue may facilitate the systemic inflammation associated with the insulin resistance of obesity. Although palmitate induces inflammation (i.e., activates proinflammatory pathways) in myotubes, the effects of fatty acids on inflammatory processes in adipocytes have not been established. Therefore, we examined the potential for palmitate, laurate, and docosahexaenoic acid (DHA) to modulate inflammation in 3T3-L1 adipocytes. Palmitate, but not DHA or laurate, induced nuclear factor kappaB (NF-kappaB)-driven luciferase activity and interleukin-6 (IL-6) expression (P < 0.05). Inhibition of fatty acyl Co-A synthase (FACS) with triacsin C suppressed palmitate-induced NF-kappaB activation (P < 0.05), but caused an additive increase in palmitate-induced IL-6 expression (P < 0.05). Disrupting mitogen-activated protein kinase/Erk kinase (MEK) and protein kinase C (PKC) activity with U0126 and Bisindolylmaleimide (Bis), respectively, suppressed palmitate-induced IL-6 expression (P < 0.05), but had no effect on NF-kappaB reporter gene activity (P > 0.05). However, the phosphoinositide-3 kinase (PI3K) inhibitor, wortmannin, alone and additively with palmitate, activated the NF-kappaB reporter gene and induced IL-6 expression (P < 0.05). Palmitate also induced the mRNA expression of tumor necrosis factor alpha (TNFalpha) (P < 0.05), but the increase in mRNA abundance was not reflected in a greater protein concentration in the media (P > 0.05). These data indicate that palmitate induces inflammation in adipocytes, and that this is not a generalized effect of all SFA. Furthermore, PI3K may act constitutively to suppress inflammation. Consequently, inhibition of this enzyme may promote and exacerbate the inflammation in adipose tissue that is associated with obesity and insulin resistance.
脂肪酸及其代谢产物可调节基因表达和免疫途径。此外,肥胖个体的循环脂肪酸浓度通常会升高,脂肪组织中的局部炎症可能会促进与肥胖胰岛素抵抗相关的全身炎症。尽管棕榈酸酯可在肌管中诱导炎症(即激活促炎途径),但脂肪酸对脂肪细胞炎症过程的影响尚未明确。因此,我们研究了棕榈酸酯、月桂酸酯和二十二碳六烯酸(DHA)调节3T3-L1脂肪细胞炎症的可能性。棕榈酸酯而非DHA或月桂酸酯可诱导核因子κB(NF-κB)驱动的荧光素酶活性和白细胞介素-6(IL-6)表达(P<0.05)。用三辛环素C抑制脂肪酰辅酶A合酶(FACS)可抑制棕榈酸酯诱导的NF-κB激活(P<0.05),但会使棕榈酸酯诱导的IL-6表达呈相加性增加(P<0.05)。分别用U0126和双吲哚马来酰亚胺(Bis)破坏丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK)和蛋白激酶C(PKC)的活性,可抑制棕榈酸酯诱导的IL-6表达(P<0.05),但对NF-κB报告基因活性无影响(P>0.05)。然而,磷脂酰肌醇-3激酶(PI3K)抑制剂渥曼青霉素单独使用以及与棕榈酸酯联合使用时,均可激活NF-κB报告基因并诱导IL-6表达(P<0.05)。棕榈酸酯还可诱导肿瘤坏死因子α(TNFα)的mRNA表达(P<0.05),但mRNA丰度的增加并未反映在培养基中更高的蛋白浓度上(P>0.05)。这些数据表明,棕榈酸酯可诱导脂肪细胞炎症,且这并非所有饱和脂肪酸的普遍作用。此外,PI3K可能持续发挥作用以抑制炎症。因此,抑制该酶可能会促进和加剧与肥胖和胰岛素抵抗相关的脂肪组织炎症。